Tuesday, October 6, 2026
25.3 C
Bengaluru

The Great Healthcare Pivot: Who Owns The Consumer Before They Become A Patient?

How wearables, diagnostics, AI and continuous monitoring are moving healthcare from episodic treatment to continuous health management

A forty-two-year-old woman wakes up with chest pain. She drives to the emergency room. She becomes a patient. That moment- the symptom, the visit, the diagnosis- has been healthcare's primary point of entry for more than a century. But what if the system had been watching her physiology for years, detecting the pattern that led to that morning long before she felt anything? In most modern healthcare systems, the system is built around an event. A person develops symptoms. They visit a doctor. Tests are ordered. A diagnosis is made. Treatment begins. Follow-up happens periodically. As a result, the healthcare industry encounters most people relatively late in their health journey, often after they have already become patients. That model is now beginning to change.

Free Membership Required

You must be a Free member to access this content.

Join Now

Already a member? Log in here

Hot this week

Indian Pharma Is Two Industries Wearing One Label

Indian pharma is often discussed as one sector. In...

Why Is the World’s Pharmacy Failing to Protect Patients from Harm?

This MedicinMan Intelligence Report follows a disturbing trail—from Arun...

Shakul Srivastava has been appointed as Senior Vice President at Indian Immunologicals Limited.

With over three decades of experience in the pharmaceutical...

The Rx–Outcomes Dichotomy: India Has Iron Tablets. Why Does Anaemia Persist?

India’s anaemia challenge is not simply about access to...

10 Years of Pharma M&A — Who’s Really Benefited?

Pharmaceutical M&A is usually discussed in the language of...

Topics

Indian Pharma Is Two Industries Wearing One Label

Indian pharma is often discussed as one sector. In...

Why Is the World’s Pharmacy Failing to Protect Patients from Harm?

This MedicinMan Intelligence Report follows a disturbing trail—from Arun...

10 Years of Pharma M&A — Who’s Really Benefited?

Pharmaceutical M&A is usually discussed in the language of...

What’s Killing Patients? Cancer or Rigged Drug Prices?

The disease is real. So is the markup. Confusing...

A Tale of Two Cities: Peptides and Prescriptions

What our health choices reveal about education, access and...

Trust Is Pharma’s Fulcrum: Are We Getting the Basics Right?

MedicinMan Intelligent Insights When Air India CEO Tewolde Gebremariam...
spot_img

Related Articles

spot_imgspot_img